D-0146-2018 Class III Terminated
FDA drug recall D-0146-2018 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Sep 20, 2017 and is designated Class III. Reason for recall: Cross contamination with other products: traces of Dapsone were found in the finished product. The recall status is terminated (terminated Sep 10, 2020). Affected quantity: 16,944 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 1, 2017
- Initiation Date
- Sep 20, 2017
- Termination Date
- Sep 10, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,944 tubes
Product description
Fluocinonide Gel USP, 0.05%, 15 g tube, Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton Ontario Canada L6T1C1, Dist. by: Taro Pharmaceuticals U.S.A . Inc. Hawthorne NY 10532, NDC 51672-1279-1
Reason for recall
Cross contamination with other products: traces of Dapsone were found in the finished product.
Distribution pattern
Nationwide
Code information
Lot #: A771026850, Exp 6/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0146-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026